Bill

Bill > H2165


MA H2165

MA H2165
To reduce fraud in prescription drug abuse testing and help prevent substance abuse


summary

Introduced
02/16/2023
In Committee
02/16/2023
Crossed Over
Passed
Dead
12/31/2024

Introduced Session

193rd General Court

Bill Summary

By Representative Fiola of Fall River, a petition of Carole A. Fiola and Paul A. Schmid, III that the Office of Medicaid be authorized to require laboratories providing toxicology testing to demonstrate functional and operational test-utilization and test-frequency control programs. Public Health.

AI Summary

This bill authorizes the Office of Medicaid to require laboratories providing toxicology testing to demonstrate functional and operational test-utilization and test-frequency control programs to ensure compliance with MassHealth's utilization and frequency requirements for clinical drug testing. Additionally, the bill deems certain out-of-state, accredited clinical laboratories eligible and qualified to participate as MassHealth fee-for-service providers and receive payment for clinical toxicology testing, provided they deliver test results to the referring healthcare provider within two business days of receiving the test specimen. The goal of this bill is to reduce fraud in prescription drug abuse testing and help prevent substance abuse.

Committee Categories

Health and Social Services

Sponsors (2)

Last Action

Accompanied a study order, see H4739 (on 07/01/2024)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Document Type Source Location
State Bill Page https://malegislature.gov/Bills/193/H2165
BillText https://malegislature.gov/Bills/193/H2165.pdf
Loading...